Member of Lyonbiopole
Promise Proteomics is a medtech company, based in France and funded in 2010.
We are a fully integrated company dedicated to innovation, development, manufacturing and registration of CE-IVD solutions.
Our main area of work:
- developing early diagnostics kits for biodefense
- developing ready-to-use kits for monitoring monoclonal antibodies (mAbXmise range of products).
Our solutions are designed to be adapted for the clinical lab.
Our solutions are combining our specific expertise: quantitative LC-MS technology and the use of stable labelled proteins as internal standards.
Nearby, Promise continues to innovate to develop tailored solutions for diagnostics.
Promise Proteomics is also providing its customers with a range of stable-labelled proteins for bioanalysis, available off the shelf or custom.
Strategic application domain: Human Medicine
Application market: Immune, AutoIm & Inflam. diseases, Neurology & Mental Health Disorders, Oncology
Type of activity: Diagnostics, Technology provider
Technologies: Analytical methods, diagnostic & Pronostic markers, Antibodies - Protein - Peptide
Created on nov. 14th, 2000 - 23 employees
Address
7, Parvis Louis Néel BHT-52A CS 20050 38040 Grenoble
Vous devez être connecté et membre de Lyonbiopôle pour voir les contacts.